Will radioimmunotherapy replace TBI?
Open Access
- 15 October 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (8) , 2601-2602
- https://doi.org/10.1182/blood-2005-08-3086
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Phase I Trial of Iodine-131 Tositumomab With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Relapsed Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2005
- A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomasBlood, 2000
- Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.Journal of Clinical Oncology, 1998